Compare ALG & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALG | HRMY |
|---|---|---|
| Founded | 1955 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 1993 | 2020 |
| Metric | ALG | HRMY |
|---|---|---|
| Price | $191.64 | $35.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $225.00 | $49.75 |
| AVG Volume (30 Days) | 114.5K | ★ 654.0K |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | N/A | ★ 50.44 |
| EPS | ★ 9.64 | 3.17 |
| Revenue | ★ $1,615,388,000.00 | $825,944,000.00 |
| Revenue This Year | $1.26 | $23.11 |
| Revenue Next Year | $5.09 | $16.15 |
| P/E Ratio | $19.59 | ★ $11.29 |
| Revenue Growth | N/A | ★ 21.13 |
| 52 Week Low | $156.30 | $25.52 |
| 52 Week High | $233.29 | $40.93 |
| Indicator | ALG | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 71.58 | 42.50 |
| Support Level | $181.47 | $34.68 |
| Resistance Level | $189.18 | $39.40 |
| Average True Range (ATR) | 4.77 | 1.25 |
| MACD | 1.58 | -0.35 |
| Stochastic Oscillator | 92.99 | 27.97 |
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.